Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG-Guided vs Standard Perfusion Assessment in Gluteal Filler Removal
NCT07808957Not yet recruiting
- Sponsor
- NV-Research
- Start
- Oct 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial of indocyanine green in soft tissue filler complication, ischemia and necrosis (2 arms), sponsored by NV-Research. Primary endpoint: Incidence of Ischemic Gluteal Flap Complications at 30 days. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
indocyanine green
03
Conditions
soft tissue filler complicationischemianecrosis
Beyond the preview
Go deeper on NCT07808957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07808957.